Medtronic picks exec to lead Covidien integration

In the wake of Medtronic's ($MDT) hefty $43 billion Covidien ($COV) acquisition, the company is gearing up by naming a new chief integration officer, Geoff Martha, who is an SVP for strategy and business development. Martha's main goal will be to provide a link between the merging medical device companies. Within Medtronic, Martha is known for his international efforts, playing a key role in the Kanghui and Lifetech Scientfic transactions in China. Story

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.